Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-13

Clinical Trial Update: Pilot HCV Direct Acting Antiviral Therapy and Metabolism [Phase 4]

View source ↗

Summary

Phase 4 pilot trial update on direct-acting antiviral therapy for hepatitis C and metabolism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Hepatitis C | Phase 4 | Status: COMPLETED